{"id":"W2120319857","doi":"10.1056/nejmoa1313984","title":"Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1500,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Chlorambucil; Obinutuzumab; Medicine; Rituximab; Internal medicine; Hazard ratio; Gastroenterology; Chronic lymphocytic leukemia; Oncology; Chemotherapy; Confidence interval; Leukemia; Cyclophosphamide; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007900941,0.0002374285,0.0007311284,0.0002667318,0.0004438497,0.0003596105,0.0001836543,0.0004557091,0.001119407],"category_scores_gemma":[0.001708327,0.0001502788,0.0004823856,0.0003869059,0.0003282014,0.0002178317,0.00029932,0.0004434786,0.00009920474],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005589147,"about_ca_system_score_gemma":0.0007315595,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000746233,"about_ca_topic_score_gemma":0.001745986,"domain_scores_codex":[0.9995086,0.0002503065,0.00004546728,0.00006182212,0.00005056266,0.00008317053],"domain_scores_gemma":[0.9989685,0.0004165543,0.0002699072,0.00002573183,0.00002219598,0.0002972371],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1999718,0.002775164,0.6789398,0.0007309334,0.0009191,0.001916037,0.0003613135,0.002779977,0.007767097,0.0002947788,0.001080438,0.1024636],"study_design_scores_gemma":[0.04385455,0.1331854,0.7955765,0.0003971597,0.002191874,0.008343086,0.0005450701,0.004990914,0.00278154,0.0008385946,0.007226755,0.00006867231],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973844,0.002065411,0.00004154398,0.00008954146,0.00001477198,0.00003555543,0.00003859256,0.000002297952,0.0003278656],"genre_scores_gemma":[0.9992269,0.0004081781,0.00009343674,0.00009075705,0.00003632105,0.00003463479,0.00006835241,5.038376e-7,0.00004084566],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001119407,"threshold_uncertainty_score":0.004178464,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01466347416376183,"score_gpt":0.2802251531773841,"score_spread":0.2655616790136222,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}